Trans-Nerolidol (Standard)
Trans-Nerolidol (Standard) is the analytical standard of trans-Nerolidol. This product is intended for research and analytical applications. trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo[1].
Product Specifications
CAS Number
40716-66-3
UNSPSC
12352211
Target
Fungal; Reference Standards
Type
Reference Standards
Related Pathways
Anti-infection; Others
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/trans-nerolidol-standard.html
Smiles
C=CC(C)(O)CC/C=C(C)/CC/C=C(C)/C
Molecular Formula
C15H26O
Molecular Weight
222.37
References & Citations
[1]Hanušová V, et al. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed Pharmacother. 2017 Nov;95:828-836.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6392283-01 0.1 mL
RECK (Reversion-inducing Cysteine-rich Protein with Kazal Motifs, hRECK, Suppressor of Tumorigenicity 15 Protein, ST15) (MaxLight 550)
Sign In for Pricing
View Details MBS6392283-02 5x 0.1 mL
RECK (Reversion-inducing Cysteine-rich Protein with Kazal Motifs, hRECK, Suppressor of Tumorigenicity 15 Protein, ST15) (MaxLight 550)
Sign In for Pricing
View Details 
LV772236 1.0 µg DNA
OR1AB1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details